Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times

Abbott Laboratories Reports Strong Earnings Despite Recent Challenges

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

Top News

Abbott Labs Skids Within A Saucer Base Despite 'Solid Results'

Abbott's earnings guidance slightly missed expectations at the midpoint Wednesday, and ABT stock fell within a saucer base.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Four Measures Taken by New York City's Government to Address the Migrant Crisis

Around 170,000 migrants have arrived in New York City since 2022, putting its shelter system and financial situation under pressure

Latin Times

Real-time glucose monitoring wearable launches in the UK – here’s how it works

The Abbott Lingo analyses a wearer’s glucose spikes and falls and offers personalised habit suggestions and coaching in response

The Independent UK

100 Years of Paying Dividends: Why You Need This Healthcare Stock

Dividend growth investors love this boring healthcare stock for three reasons: Growth, financial stability, and 100 years of paying dividends.

Barchart

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

The Independent UK

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?

The good times keep rolling for Novo Nordisk and its weight-loss drugs. But it's bad news for some medical device stocks.

Investors Business Daily

Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review

The major indexes saw significant loses as Treasury yields soared. Tesla tumbled on earnings while Nvidia fell on fresh China chip curbs.

Investors Business Daily

Abbott Shrugs Off 'Tizzy' Over Weight-Loss Drugs, Surging On Beat And Raise

Abbott stock popped Wednesday after shrugging off concerns that new diabetes and weight-loss drugs will undercut its diabetes devices.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Worried About a Recession? Protect Your Portfolio With These 3 Resilient Stocks

With geopolitical tensions rising, here are three stocks from different sectors that have the ability to weather this storm.

Investors Business Daily

Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle

Abbott stock jumped Thursday after showing patients taking popular diabetes and weight-loss drugs are more compliant with their CGMs.

Fortune

The companies electrifying cars—including Tesla—top Fortune's Change the World list

Fortune's Change the World list is a stong statement that business success can't be measured by financial metrics alone.

Roll Call

After infant formula crisis, lawmakers look to donor milk - Roll Call

Lawmakers want to make donor breast milk more mainstream but advocates warn the alternative comes with risk.

Get all your
news in one place.

100’s of premium titles.
One news app.

Cinemablend

Abbott Elementary’s Quinta Brunson On What Gregory And Jacob’s Relationship Could Look Like In Season 3

Abbott Elementary star and creator Quinta Brunson teases what Gregory and Jacob's relationship could look like in the upcoming third season.

Investors Business Daily

Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review

The Dow Jones lead the market rally, while Tesla, Netflix and Taiwan Semiconductor hit growth stocks Thursday.

Chicago Tribune

Abbott’s COVID-19 test sales dive by nearly 90%

Abbott Laboratories’ sales of COVID-19 tests fell by a whopping 89% during the second quarter of this year compared with the same time last year — a drop that comes as the world attempts to move on from the pandemic.

Investors Business Daily

Abbott Flirts With Breakout After Notching A Recovery In Not One, But Two Businesses

Two of Abbott's businesses are recovering from recent setbacks, helping stoke a second-quarter beat Thursday and pushing Abbott stock higher.

Fortune

Infant formula startup Bobbie acquires Nature's One

The 2022 infant formula shortage inspired Bobbie's CEO to look for ways to expand.

Salon

Formula shortage fueled unsafe feeding

Many parents watered down formula or used expired formula to survive last year's formula shortage

The Independent UK

Deadly germ behind infant formula shortage will join CDC watchlist of bad bugs

Federal health officials will start formally tracking infections caused by the rare but potentially deadly germ that sickened babies and triggered a nationwide shortage of infant formula last year

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.